DIN 02403269 — JENTADUETO 850 MG; 2.5 MG
JENTADUETO is a tablet of Linagliptin / Metformin marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Linagliptin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02403269
- Brand name
- JENTADUETO
- Active ingredient
- Linagliptin / Metformin
- Strength
- 850 MG; 2.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Health Canada status
- MARKETED
- Drug class
- Dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination (antidiabetic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Linagliptin / Metformin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02403277 | JENTADUETO | 1000 MG; 2.5 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02403250 | JENTADUETO | 2.5 MG; 500 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |